A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.
According to the U.S. Centers for Disease Control and Prevention, prostate cancer is the second leading cause of cancer death among men. One of the standard approaches for the diagnosis and treatment ...
Each year, more than a million transrectal biopsies are performed in the United States. The primary technique for diagnosing and monitoring prostate cancer, a transrectal biopsy, entails removing ...
Chinese researchers have built a machine-learning nomogram that combines biparametric MRI radiomics, clinical variables, and ...
Prostate cancer patients' adherence to medication while on abiraterone acetate (AA) therapy. This is an ASCO Meeting Abstract from the 2014 Genitourinary Cancers Symposium. This abstract does not ...
Epidemiologic Analysis Along the Mevalonate Pathway Reveals Improved Cancer Survival in Patients Who Receive Statins Alone and in Combination With Bisphosphonates We compared the performance of 20 ...
LAS VEGAS (CN) - A federal jury on Thursday convicted Las Vegas urologist Michael Stanley Kaplan of reusing single-use needle guides while treating patients for prostate conditions. Kaplan, 59, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results